These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24308837)

  • 1. The intelligent use of systemic glucocorticoids in rheumatoid arthritis.
    Mercieca C; Kirwan JR
    Expert Rev Clin Immunol; 2014 Jan; 10(1):143-57. PubMed ID: 24308837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():26-9. PubMed ID: 23259655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.
    Santiago T; Jacobs JW; Saag KG; Buttgereit F; Pereira da Silva JA
    Acta Reumatol Port; 2015; 40(1):10-22. PubMed ID: 25844966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified release prednisone in patients with rheumatoid arthritis.
    Jacobs JW; Bijlsma JW
    Ann Rheum Dis; 2010 Jul; 69(7):1257-9. PubMed ID: 20525834
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis.
    Alten R
    Expert Rev Clin Immunol; 2012 Feb; 8(2):123-33. PubMed ID: 22288450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
    Bijlsma JW; Jacobs JW
    Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F; Gibofsky A
    Expert Opin Pharmacother; 2013 Jun; 14(8):1097-106. PubMed ID: 23594208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current relevance and use of prednisone in rheumatoid arthritis.
    Krasselt M; Baerwald C
    Expert Rev Clin Immunol; 2014 May; 10(5):557-71. PubMed ID: 24717015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid treatment in rheumatoid arthritis.
    Rau R
    Expert Opin Pharmacother; 2014 Aug; 15(11):1575-83. PubMed ID: 24856989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids in the treatment of rheumatoid arthritis.
    Bijlsma JW; Jacobs JW; Buttgereit F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S34-6. PubMed ID: 26457916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis.
    Caporali R; Todoerti M; Scirè CA; Montecucco C; Cutolo M
    Neuroimmunomodulation; 2015; 22(1-2):104-11. PubMed ID: 25227117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis.
    van der Goes MC; Jacobs JW; Bijlsma JW
    Curr Opin Rheumatol; 2016 May; 28(3):289-96. PubMed ID: 26962704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Kirwan J; Power L
    Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Lancet; 2008 Jan; 371(9608):205-14. PubMed ID: 18207016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone chronotherapy.
    Spies CM; Cutolo M; Straub RH; Burmester GR; Buttgereit F
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S42-5. PubMed ID: 22018182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.
    Strehl C; van der Goes MC; Bijlsma JW; Jacobs JW; Buttgereit F
    Expert Opin Investig Drugs; 2017 Feb; 26(2):187-195. PubMed ID: 28043173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are glucocorticoids harmful to bone in early rheumatoid arthritis?
    Lems WF
    Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C
    Drug Des Devel Ther; 2016; 10():1047-58. PubMed ID: 27022244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.